Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2025-12-25 @ 7:37 PM
NCT ID:
NCT03493932
Group ID:
EG000
Title:
Recurrent Glioblastoma Patients
Description:
Nivolumab: OPDIVO is a human programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.
BMS-986016: Anti-Lymphocyte Activation Gene-3 antibody undergoing clinical evaluation by Bristol-Myers Squibb
Deaths Number Affected:
13
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
13
Other Number Affected:
1
Other Number At Risk:
13
Study:
NCT03493932
Results Section:
NCT03493932
Adverse Events Module:
NCT03493932